Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2015-2021


The Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2015-2021 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies

Publication date
October 2021
Number of pages
Product type
Research report
Available formats
PDF document
Report edition

The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 - 2021 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies.


This report provides details of the latest licensing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to date, the report provides details of licensing agreements from 2015 to 2021.


There has been a long standing willingness for parties to enter licensing deals. Such deals enable both parties to benefit from the upside of a big R&D win, whilst mitigating the risks of going it alone in the risky preclinical and clinical development stages.


Licensing is a specific type of partnering deal whereby the parties to the deal agree to commercialize a compound, product or technology.


Specifically, licensing is the granting of permission to use intellectual property rights, such as trademarks, patents, or technology, under defined conditions


There are several forms of licensing deal. Traditional licensing arrangement whereby an owner of intellectual property (the licensor) provides access to its technology to another company (the licensee) in return for agreed payments and royalties on subsequent sales of product(s) derived from the intellectual property.


In more recent times, licensing is often the outcome of a successful period of collaboration on the research and development of a technology or compound, resulting in a product which can be commercialized. In this situation, the licensing agreement governs who has permission to commercialize and what payments are due should commercialization proceed.


Other forms of licensing such as sub-licensing and cross-licensing are also explored, with examples provided together with listing of recent deals in pharma, biotech and diagnostics.


The report provides a detailed understand and analysis of how and why companies enter licensing deals. The majority of deals are multicomponent whereby the licensee retains either a right or option to license to commercialize the resultant product of the research collaboration. There are also numerous pure licensing deals whereby the products originator takes on a development/commercialization partner in order to maximize a technologies/products prospects.


Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.


This report contains a comprehensive listing of all licensing deals announced since 2015 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.


Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.


The initial chapters of this report provide an orientation of licensing deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in licensing as well as a discussion on the merits of the type of deal.


Chapter 3 provides an overview of the structure of licensing deals. The chapter includes numerous case studies to enable understanding of both pure licensing deals and multicomponent deals where collaborative R&D forms a part.


Chapter 4 provides a review of the leading licensing deals since 2015. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.


Chapter 5 provides a review of the top 25 most active biopharma companies in licensing. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.


Chapter 6 provides a comprehensive review of licensing financials for deals announced since 2015, including headline value, upfront, milestone payments and royalty rates, providing both benchmark data and access to individual deal financials.


Chapter 7 provides a comprehensive and detailed review of licensing deals signed and announced since 2015 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.


The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.


The report also includes numerous table and figures that illustrate the trends and activities in licensing deal making since 2015.


In addition, a comprehensive appendix is provided organized by licensing company A-Z , stage of development, therapeutic target, technology type and deal type definitions. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


In conclusion, this report provides everything a prospective dealmaker needs to know about licensing partnering in the research, development and commercialization of technologies and products.


Key benefits


Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 - 2021 provides the reader with the following key benefits:


  • In-depth understanding of licensing partnering deal trends since 2015
  • Analysis of the structure of licensing agreements with real life case studies
  • Comprehensive listing of licensing deals since 2015, together with deal terms, value and press release
  • Comprehensive access to actual licensing contracts entered into by the world’s life science companies
  • Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
  • Insight into the terms included in a licensing agreement, together with real world clause examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies


Report scope


Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 - 2021 is intended to provide the reader with an in-depth understanding of the licensing trends and structure of deals entered into by leading life science companies worldwide.        


Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 - 2021 includes:


  • Trends in licensing dealmaking in the biopharma industry since 2015
  • Analysis of licensing deal structure
  • Case studies of real-life licensing deals
  • Comprehensive listing of licensing deals since 2015
  • Access to licensing contract documents
  • Key financial bnchmarks for headline, upfront, milestone and royalty rates
  • The leading licensing deals by value since 2015
  • Most active licensing dealmakers since 2015
  • The leading licensing partnering resources


In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 - 2021 available deals and contracts are listed by:


  • Company A-Z
  • Headline value
  • Therapeutic area
  • Technology type


Each deal title links via Weblink to an online version of the actual deal record and where available, contract document, providing easy access to each contract document on demand.


The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 - 2021 report provides comprehensive access to available contract documents for licensing deals. Analyzing actual contract agreements allows assessment of the following:


  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How do milestone align with clinical stage development phases?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2015-2021 provides the reader with the following key benefits:


  • In-depth understanding of licensing partnering deal trends since 2015
  • Insight into the terms included in a licensing agreement, together with real world clause examples
  • Identify leading licensing deals by value since 2015
  • Identify the most active licensing dealmakers since 2015
  • Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
  • Full listing of  licensing deals by company A-Z, deal value, phase of development, deal type, therapy and technology focus
  • Comprehensive access to licensing deals entered into by the world’s biopharma companies, together with contract documents if available
  • Detailed access to actual licensing contracts entered into by the leading fifty big pharma and big biotech companies
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary


Chapter 1 – Introduction


Chapter 2 – Trends in licensing deal making


2.1. Introduction

2.2. Definition of licensing deals

2.3. Success factors for licensing deals

2.4. When licensing can be useful

2.5. Attributes of licensing deals

2.6. Trends in licensing deals since 2015

2.6.1. Licensing deal making by year since 2015

2.6.2. Licensing deal making by phase of development since 2015

2.6.3. Licensing deal making by industry sector since 2015

2.6.4. Licensing deal making by therapy area since 2015

2.6.5. Licensing deal making by technology type since 2015

2.6.6. Licensing deal making by most active company since 2015

2.7. Option to license

2.8. Adding co-promotion to the mix

2.9. The future of licensing deals


Chapter 3 – Overview of licensing deal structure


3.1. Introduction

3.2. Pure versus multi-component licensing deals

3.3. Pure licensing agreement structure

3.3.1. Example licensing agreements

3.3.1.a. Case study 1: Ignyta – Nerviano Medical Sciences

3.3.1.b. Case study 2: Sanofi - Pozen

3.4. Licensing rights as part of a wider alliance agreement

3.4.1. Example licensing clauses

3.4.1.a. Case study 3: 4D Molecular Therapeutics – UniQure

3.4.1.b. Case study 4: Kyowa Hakko Kirin – Ultragenyx Pharmaceuticals

3.4.2. Example licensing option right clauses

3.4.2.a. Case study 5: Forest Laboratories - Trevena

3.4.2.b. Case study 6: Abbvie – Receptos


Chapter 4 – Leading licensing deals


4.1. Introduction

4.2. Top licensing deals by value


Chapter 5 – Top 25 most active licensing dealmakers


5.1. Introduction

5.2. Top 25 most active licensing dealmakers


Chapter 6 – Licensing deal term financials


6.1. Introduction

6.2. Licensing partnering headline values

6.3. Licensing deal upfront payments

6.4. Licensing deal milestone payments

6.5. Licensing royalty rates


Chapter 7 – Licensing contract directory since 2015


7.1. Introduction

7.2. Licensing deals with contracts since 2015




Appendix 1 – Licensing dealmaking by companies A-Z

Appendix 2 – Licensing dealmaking by industry sector

Appendix 3 – Licensing dealmaking by stage of development

Appendix 4 – Licensing dealmaking by therapy area

Appendix 5 – Licensing dealmaking by technology type


About Wildwood Ventures


Current Partnering

Current Agreements

Recent report titles from Current Partnering




Figure 1: Definition of licensing

Figure 2: Situations where licensing can prove useful

Figure 3: Key attributes of a licensing deal

Figure 4: Trends in licensing deal announcements since 2015

Figure 5: Licensing deals signed at each phase of development since 2015

Figure 6: Licensing deals by industry sector since 2015

Figure 7: Licensing deals by therapy area since 2015

Figure 8: Licensing deals by technology type since 2015

Figure 9: Top 25 most active licensing dealmakers sinnce 2015

Figure 10: Licensing agreements – what should a contract include?

Figure 11: Components of the licensing deal structure

Figure 12: Top licensing deals by value since 2015

Figure 13: Most active licensing dealmakers since 2015

Figure 14: Licensing deals with a headline value

Figure 15: Licensing deals with an upfront value

Figure 16: Licensing deals with a milestone value

Figure 17: Licensing deals with a royalty rate value

Pricing options

  • $3,495: single-user
  • $5,245: multi-user
  • $10,495: single site license
  • $17,495: global site license


A full explanation of license type definitions can be found here.


Our guarantee


Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.


Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)


Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.


Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.


Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.


Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

2A, 2bPrecise, 2X Oncology, 3a-diagnostics, 3B Pharmaceuticals, 3D Medicines, 3E Bioventures Capital, 3M, 3M Drug Delivery Systems, 3P Biopharmaceuticals, 3rd People’s Hospital of Shenzhen, 3SBio, 4D Molecular Therapeutics, 4D Pharma, 4SC, 8E6Tong, 9 Meters Biopharma, 10X Genomics, 23andMe, 48Hour Discovery, 221b Foundation, A&B Company, A*STAR Agency for Science, Technology and Research, A1 Group, A2 Biotherapeutics, Aadi Bioscience, Aardvark Therapeutics, Aarhus University, AAVnerGene, AazeinTx, Abba Import Export, AB Biosciences, Abbisko Therapeutics, Abbott Laboratories, Abbott Vascular Devices, Abbvie, Abcam, AbCellera, AbClon, Abcuro, Ab E Discovery, Abeona Therapeutics, Abide Therapeutics, Ability Pharmaceuticals, Ab Initio, ABL Bio, Ablexis, Ablynx, AbMed, Abmuno Therapeutics, Aboundbio, Abound Bio, Abpro, AbSci, Absorption Systems, Abuse Deterrent Pharmaceuticals, Abveris, ABX, Abzena, Acacia Pharma, Acacia Research, ACADIA Pharmaceuticals, Acasti Pharma, AC Bioscience, Accelerate Technologies, Accent Therapeutics, Accera Pharmaceuticals, Accord Healthcare, ACEA Therapeutics, Acella Pharmaceuticals, Acelrx Pharmaceuticals, Acenzia, Acepodia, Aceragen, Acer Therapeutics, Acerus, ACE Solutech, Acetylon Pharmaceuticals, Achieve Life Science, Achillion Pharmaceuticals, AC Immune, Aclaris Therapeutics, Acorda Therapeutics, Acoustic MedSystems, Acrotech Biopharma, Actavis (acquired by Watson), Actelion, Acticor Biotech, Actimed Therapeutics, Actinobac Biomed, Active Biotech, Active Motif, ActiveSite, ActLight, ActualEyes, Actuated Cardio Engineering, Actuated Medical, Acturum Life, Acucela, Acumen Pharmaceuticals, Acura Pharmaceuticals, Acutus Medical, Adagene, AdAlta, Adama, Adamas Pharmaceuticals, Adamis Pharmaceuticals, Adapsyn Bioscience, Adaptimmune, Adaptive Biotechnologies, Adaptive Phage Therapeutics, Adapt Pharma, AdaptVac, Adare Pharma Solutions, ADC Therapeutics, Addex Therapeutics, Adept Neuro, Adhera Therapeutics, Adhesys Medical, Adial Pharmaceuticals, Adicet Bio, Adimab, Aditx Therapeutics, Adlai Nortye, adMare BioInnovations, Admedus, Adnab, Adocia, Adrestia, ADT Pharmaceuticals, Aduro BioTech, Advaccine Biotechnology, Advaite, Advanced Accelerator Applications, Advanced Animal Diagnostics, Advanced BioInformatics, Advanced Biological Laboratories, Advanced Catheter Therapies, Advanced Dosage Forms, Advanced Human Imaging, Advanced Medical Solutions, Advanced Nuclear Medicine Ingredients, Advanced Proteome Therapeutics, Advance Pharmaceutical, Advanz Pharma, Advaxis, Adverum Biotechnologies, Aegerion Pharmaceutical, Aegis Life, Aegis Therapeutics, Aeglea BioTherapeutics, Aelan Cell Technologies, Aelian Biotechnology, Aelis Pharma, Aerami Therapeutics, Aerie Pharmaceuticals, Aeromics, Aerpio Pharmaceuticals, AEterna Zentaris, Aethlon Medical, Aevi Genomic Medicine, Aevitas Therapeutics, AffaMed Therapeutics, Affibody, Affilogic, Affimed Therapeutics, Affinia Therapeutics, Affinivax, AffyXell Therapeutics, AFT Pharmaceuticals, Agalimmune, AGC Asahi Glass, Agensys, Agenus Bio, AgeX Therapeutics, Agile Biodetection, Agilis Biotherapeutics, Agios Pharmaceuticals, AgMedica Bioscience, AgomAb Therapeutics, AgonOx, AgPlenus, AgriCann Solutions, Agroresults, AGTC, Aguettant, AHN Autoimmunity Institute, AiCuris, AIG Hospitals, AIkido Pharma, AIMM Therapeutics, Aimmune Therapeutics, AIT Therapeutics, AiVita Biomedical, Ajinomoto, AJU Pharma, Akaal Pharma, Akari Therapeutics, AkaRx, Akcea Therapeutics, Akebia Therapeutics, Aker BioMarine, Akero Therapeutics, Akers Biosciences, Akeso Biopharma, Akili Interactive Labs, Akonni Biosystems, Akorn, Akouos, Akrevia Therapeutics, Akriveia Therapeutics, Albany Molecular Research, Alba Therapeutics, Albert Einstein College of Medicine, Alcon Laboratories, Alcyone Lifesciences, Alder Biopharmaceuticals, Aldevron, Aldeyra Therapeutics, Alector, Aleta Biotherapeutics, Aleva Neurotherapeutics, Alexion Pharmaceuticals, Alex Therapeutics, Alexza Pharmaceuticals, Alfasigma, Algae-C, AlgaEnergy, Algenex, Aligo, Aligos Therapeutics, Alimentary Health, AliveCor, Alive Sciences, Alivio Therapeutics, ALK-Abello, Alkahest, Alkem Laboratories, Alkermes, Allakos, Allarity Therapeutics, AllCells, Allecra Therapeutics, Allegheny General Hospital, Allegheny Technologies, Allegro Ophthalmics, Allele Biotechnology and Pharmaceuticals, Allen Institute for Brain Science, Allergan, Allergan Aesthetics, AllerGenis, Alliance BioEnergy Plus, Alliance Pharma, Allied-Bristol Life Sciences, Allied Corp, Alligator Bioscience, Allist Pharma, Allogene Overland Biopharm, Allogene Therapeutics, Alloksys Life Sciences, AlloVir, AllyAlign Health, Almirall, Alnylam Pharmaceuticals, Alopexx, Alpha Biopharma, Alpha Cancer Technologies, Alphaeon, Alphageneron Pharmaceuticals, Alphamab Biopharmaceuticals, Alphamab Oncology, Alpine Immune Sciences, ALS Biopharma, Altamira Bio, Altamira Pharma, Altan Pharma, Alteogen, Alterity Therapeutics, Alternative Solutions, Alternavida, Altesa Biosciences, Alto Neuroscience, Altum Pharmaceuticals, Altus Formulation, Alvit LCS Pharma, Alvogen, Alvotech, Alytas Therapeutics, Alzamend Neuro, AlzeCure Pharma, Alzheon, Alzyn, AM-Pharma, Amag Pharmaceuticals, Amarantus BioSciences, Amarin, Amasa Therapeutics, Ambrx, Ambys Medicines, AM Chemicals, Amegabiotech, A Menarini Diagnostics, Amendia, Amend Surgical, American BriVision, American Cancer Society, American CryoStem, American Speech-Language-Hearing Association, American Type Culture Collection (ATCC), Amerigen Pharmaceuticals, Amfora, Amgen, Amneal Pharmaceuticals, Amolyt Pharma, AMO Pharma, Amorsa Therapeutics, AmplyCell, Amplyx Pharmaceuticals, AMR, Amring Pharmaceuticals, Amryt, Amunix, Amyris, Amzell, AN2 Therapeutics, AnaBios, Anagenesis Biotechnologies, Anahit, ANANDA Scientific, Anatara Lifesciences, Anchiano Therapeutics, Andor Pharmaceuticals, Angelini Pharma, AnGes MG, Angiochem, Angiocrine Bioscience, Angiodynamics, Angion Biomedica, Angionetics, Angios, AngioSoma, Angiostem, AnHeart Therapeutics, Anima Biotech, Animalcare, Animal Life Sciences, ANI Pharmaceuticals, Anivive Lifesciences, Anixa Biosciences, Anji Pharma, Annias Immunotherapeutics, ANP Technologies, Antares Pharma, Antengene, Anteris Bio, Anthos Therapeutics, Antibe Therapeutics, Antibody Solutions, Antigen Express, Antios Therapeutics, Antisense Therapeutics, AntriaBio, Apceth, APC Therapeutics, Apeiron Biologics, Apellis Pharmaceuticals, Aperion Biologics, Apex Global Brands, Apexian Pharmaceuticals, Apexigen, Aphria, Aplagon, Apogenix, ApolloBio, Apollomics, Apollo Therapeutics, Apotex, Appello Pharmaceuticals, Appia Bio, Appili Therapeutics, Applied BioCode, Applied Biology, Applied BioSciences, Applied Botanics, Applied DNA Sciences, Applied Molecular Transport, Applied StemCell, APR Applied Pharma Research, Aprecia Pharmaceuticals, Apricity Health, Apricus Biosciences, APRINOIA Therapeutics, Apsen Farmacutica, AptaBio Therapeutics, AptarGroup, Aptarion biotech, Aptar Pharma, Aptevo Therapeutics, Aptinyx, Aptorum Group, Aptose Biosciences, Aquavit Pharmaceuticals, Aquestive Therapeutics, Aquinox Pharmaceuticals, Aquitaine Science Transfert (SATT Aquitaine), Aragen Bioscience, Aralez Pharmaceuticals, Aratana Therapeutics, Aravive Biologics, Arbele, Arbor Biotechnologies, Arbormentis, Arbutus, ARCA Biopharma, Arcadia Biosciences, Arcadia Consumer Healthcare, ArcDia, Arcellx, Arch Biopartners, ArcherDX, Arcis Biotechnology, Arcoral Pharma, ARC Therapeutics, Arctic University of Norway, Arctic Vision, Arcturus Therapeutics, Arcus Biosciences, Arcutis Biotherapeutics, Ardelyx, Arecor, Arena Pharmaceuticals, Ares Genetics, arGEN-X, Argentum Pharmaceuticals, argenx, Argon Medical Devices, Argos Therapeutics, Ariad Pharmaceuticals, Aridis Pharmaceuticals, Ariosa Diagnostics, Arista Cereal Technologies, Aristea Therapeutics, Arizona State University, Arjuna Naturals, Ark Biosciences, Armetheon, ARMO Biosciences, Arno Therapeutics (inactive since 2017), Aro Biotherapeutics, ArQule, Arradiance, Arrakis Therapeutics, Array Biopharma, Arrien Pharmaceuticals, ArriVent Biopharma, Arrowhead Pharmaceuticals, Arrow Pharmaceuticals, Arrys Therapeutics, Arsanis Biosciences, ArsenalBio, ARS Pharmaceuticals, Artelo Biosciences, Arthrex, Artios Pharma, Artiva Biotherapeutics, Artizan Biosciences, Aruvant Sciences, Arvelle Therapeutics, Arvinas, Asahi Kasei, Asana Medical, Ascendance Biotechnology, Ascend Wellness, Ascenion, Ascensia Diabetes Care, Ascentage Pharma, Ascletis, ASC Therapeutics, Asia Green Biotechnology, Asieris MediTech, ASKA Pharmaceuticals, AskAt, AS Kevelt, Asklepios Biopharmaceutical, Aslan Pharma, Aspargo Laboratories, Aspen Holding, Aspen Park Pharmaceuticals, Aspen Pharmacare Canada, Aspire Health Science, Assembly Biosciences, Assistance Publique-Hôpitaux de Paris, Astellas Pharma, Astellas Pharma Europe, Asterias Biotherapeutics, Astex Pharmaceuticals, AstraZeneca, Astrea Bioseparations, Astute Medical, Asuragen, Asylia Therapeutics, Asymptote, Atara Biotherapeutics, Atea Pharmaceuticals, Athena Bioscience, Athenex, Athersys, Athinoula A Martinos Center for Biomedical Imaging, Athira Pharma, Atlante Biotech, Atlantic Healthcare, Atomwise, Atonco, Atossa Therapeutics, Atreca, Attune Medical, ATUM, Atvio Biotech, aTyr Pharma, Aucta Pharmaceuticals, Audax Medical, Audentes Therapeutics, Audio Cardio, Auditus, AUM Biotech, Aura Biosciences, Auransa, AuraVax Therapeutics, Aurigene Discovery Technologies, Aurinia Pharmaceuticals, Aurobindo Pharma, Aurora Cannabis, Aurum Ceramic Dental Laboratories, AusHealth, Australian Biotechnologies, Australian Research Council, Autifony Therapeutics, Autobahn Therapeutics, Autolus, Automation Anywhere, Autotelic, Autotelic BIO, Auxly Cannabis Group, Avacta, Avactis Biosciences, Avadel Pharmaceuticals, Avalanche Biotechnologies, Avalon GloboCare, AvantGen, Avaria Health & Beauty, Avectas, Avenue Therapeutics, AVEO Oncology, AveXis, Avicanna, Avidity Biosciences, Avion Pharmaceuticals, Avior Bio, Aviragen Therapeutics, AVIR Pharma, Avita Therapeutics, Avitide, Avrobio, Axcelead Drug Discovery Partners, AXIM Biotechnologies, Axiogenesis, Axis Lighting, Axis Therapeutics, AxoSim, Axovant Gene Therapies, Axsome Therapeutics, Axxam, Axxess Pharma, Ayala Pharmaceuticals, Aytu BioPharma, Aziyo Biologics, AzurRx BioPharma, Bach Biosciences, Back-A-Line, Bactevo, Baergic Bio, Baker IDI Heart and Diabetes Institute, BAKX Therapeutics, Baliopharm, Banyan Biomarkers, Barer Institute, Basilea Pharmaceutica, BAS Research, Batavia Biosciences, BATM, Battelle, Baudry Laboratory, Bausch & Lomb, Bausch Health Companies, Bavarian Nordic, Baxalta, Bayer, Bayer Animal Health, Bayer Healthcare, Baylor College, Baylor College of Medicine, Baylor Genetics, Baylor Miraca Genetics Laboratories, Baylor Scott and White Research Institute, BayPAT, Bay State Milling Company, Bazelet, BB100, BDD Pharma, Beacon Discovery, Beactica, Beam Therapeutics, Beckman Research Institute of City of Hope, Becton Dickinson, BeiGene, Beijing InnoCare Pharma, Beijing SL Pharma, Beijing Strong Biotechnologies, Beijing Tide Pharmaceutical, Beijing University of Chinese Medicine, Belfor, Bellerophon Therapeutics, Bellicum Pharmaceuticals, Ben-Gurion University, Benaroya Research Institute, Bened Biomedical, BenevolentAI, Benitec Biopharma, Benson Hill Biosystems, Benuvia Therapeutics, Berkeley Lights, Berlin Chemie, Beroni Group, Bertech Diagnostics, Besins Healthcare, Beth Israel Deaconess Medical Center, Betta Pharmaceuticals, BetterLife Pharma, BevCanna, Beyondspring Pharmaceuticals, BGN Technologies, Bhang, Bharat Biotech, BHVI, BHV Pharmaceuticals, Bial, BIA Separations, Bicycle Therapeutics, Biedermann Motech, Bill and Melinda Gates Foundation, Bintai Kinden, Bio-Gate, Bio-Rad Laboratories, Bio-Techne, Bio-Thera Solutions, bioAffinity Technologies, BioAge Labs, BioArctic Neuroscience, BioArdis, biOasis Technologies, BioAtla, BioAxone BioSciences, BioCardia, Biocare Medical, Biocept, Bioceres, Bioceros, Biocodex, Biocon, BioCorRx, BioCryst Pharmaceuticals, Biocytogen, BioDelivery Sciences, Bio DG, Biodirection, Bioeq IP, Bio Farma, BioGaia, Biogen, BioGenetics, BioGen Medical, Bioharmony Therapeutics, Biohaven Pharmaceutical Holding, BioHEP Technologies, BioInvent, Biokit, BioLab Sciences, BioLamina, BioLegend, BiolineRX, Biolin Scientific, BioLite Japan, Biologix FZCo, Biolojic Design, BioMarin Pharmaceutical, Biomed, Biomedical Advanced Research and Development Authority, Biomerica, Biomerics, bioMerieux, Biomm, Biomunex Pharmaceuticals, BiomX, Biond Biologics, Bioneer, Bionomics, BioNova Pharmaceuticals, BioNovion, Bionovus Life Sciences, BioNTech, Bionure, BionX Medical Technologies, Bioo Scientific, Bio Palette, BioPharma Forest, BioPhausia, Bioprojet, Bioptic, BioQ Pharma, BioRAE, BioRap Technologies, BioReliance, Biosceptre International, Biosearch Technologies, BioSense Global, Biosenta, BioSilta, BioSkryb, Biosolution, Biosplice, BioSyent Pharma, Biosynth, Biotectix, Biotest, BioTheryX, Biotheus, Biotoscana Farma, Biotricity, BioVaxys, Bioventus, Bioverativ, BioWa, BirchBioMed, Bird Foundation, Birdie Biopharmaceuticals, Biscayne Neurotherapeutics, Bison & Rose, Bixink Therapeutics, BL&H, Blackford, BlackThorn Therapeutics, Blanver, BlinkBio, BliNK Biomedical, Bliss Biopharmaceutical, Bloom Science, Bluebird Bio, Bluechiip, Blue Earth Diagnostics, Blue Note Therapeutics, Blueprint Medicines, BlueRock Therapeutics, Bluestar Alliance, Blue Water Vaccines, BMV Medica, BNC Korea, BODIMETRICS, Body Labs, Boehringer Ingelheim, Boeing Company, Bolt Biotherapeutics, Bone Biologics, Bone Solutions, Bone Therapeutics, Bonutti Skeletal Innovations, Bophelo Bioscience & Wellness, Boragen, Bora Pharmaceuticals, Boryung Pharmaceutical, Bosch, Boston Immune Technologies and Therapeutics, Boston Pharmaceuticals, Boston Scientific, Boston Therapeutics, Boston University, Botanisol, BoyaLife, Braeburn Pharmaceuticals, BrainLAB, Breathe ECig, Breathtec BioMedical, Breath Therapeutics, Breckenridge Pharmaceuticals, BriaCell Therapeutics, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, Bridge Medicines, BridGene Biosciences, Brigham and Women's Hospital, Bright Future Pharmaceutical Lab, Brighton Biotech, Bright Peak Therapeutics, Brii Biosciences, Brill Pharma, BRIM Biotechnology, Brink Biologics, Bristol-Myers Squibb, Broad Institute, BroadMed, Broda Technologies, Brooklyn ImmunoTherapeutics, Brown University, Bruker, Bryn Pharma, BryoLogyx, BTG, BTS Research (BTS), Buck Institute for Age Research, Bugworks, Butantan Institute, Byondis, Byrne Medical, C-Bridge Capital, C2N Diagnostics, C3i, C4 Therapeutics, C4X Discovery, Cabaletta Bio, Cadent, Cadent Therapeutics, Cadila Pharmaceuticals, Caelum Biosciences, Caffeluxe, Caladrius Biosciences, Calico, Calidi Biotherapeutics, California Institute for Biomedical Research, California Institute for Quantitative Biosciences (QB3), California Institute of Technology, Calimmune, Calithera Biosciences, Calixar, Calliditas Therapeutics, Calviri, Calypso Biotech, Calyxt, Camarus, Cambridge Cognition, Cambridge Enterprise, Cambridge Epigenetix, Cambridge Research Biochemicals, CamelBak, CAMP4 Therapeutics, Camurus, Can-Fite BioPharma, Canada House Wellness Group, Canaf Therapeutics, CanBas, CANbridge Life Sciences, CancerLinQ, Cancer Prevention Pharmaceuticals, Cancer Research Technology, Cancer Research UK, Cancer Targeted Technology, CanCure, Candela, Cannabis OneFive, CannaHoldCo, CannaRoyalty, CannaSkin, Cannassure Therapeutics, Cannidex Brands, CanniMed Therapeutics, CannPal Animal Therapeutics, Canntab Therapeutics, Canopy Biosciences, Canopy Growth, CanProbe, Cantabria Pharma, Cantargia, Cantex Pharmaceuticals, CAO Pharmaceuticals, Capricor Therapeutics, Caprion Proteomics, Capsigen, Cara Therapeutics, Caraway Therapeutics, Cardiff University, Cardinal Health, CardioFocus, Cardiogen Sciences, Cardiome Pharma, CardioSert, Cardiovascular Solutions of Central Mississippi, Cardiowise, Cardurion Pharmaceuticals, CareDx, Caribou Biosciences, Carina Biotech, Carisma Therapeutics, Carmel Pharma, Carmine Therapeutics, Carmot Therapeutics, Carna BioSciences, Carpegen, Carrick Therapeutics, Cascade Pure, Cascadian Therapeutics, Casebia Therapeutics, Case Western Reserve University, CASI Pharmaceuticals, Casma Therapeutics, Cassiopea, Castle Creek Pharmaceuticals, Catabasis Pharmaceuticals, Catalent, Catalyst Biosciences, Catalyst Pharmaceutical Partners, Catalyst Pharmaceuticals, Catamaran Bio, Catholic University Leuven, CavoGene LifeSciences, CB2 Therapeutics, CBD Solutions, CBT Pharmaceuticals, Cedars-Sinai Medical Center, Cedilla Therapeutics, Celcuity, Celdara Medical, Celgene, Celimmune, Cella Therapeutics, Cell Care Therapeutics, Cell Design Labs, Cellecta, Cellectar Biosciences, Cellectis, Cellectricon, Cellenkos, Cellerant Therapeutics, Cellesce, CellGenix, Cell Guidance Systems, Celling Biosciences, Cellix Bio, Cell Medica, Cell Mogrify, CellProThera, CellSight Technologies, Cell Source, Celltech, Cell Therapy, Cell Therapy Catapult, Cellth Systems, Celltrion, Cellular Biomedicine, Cellular Dynamics International, Cellular Engineering Technologies, Cellvation, Celonic, Celsee, Celsion, Celsius Therapeutics, Celtic Biotech, Celularity, Celyad, Cend Therapeutics, Center for Cancer Research, Centre for Drug Research and Development (CDRD), Centre For The Commercialization Of Antibodies And Biologics, Centrexion, Centro de Investigación Biomédica en Red de Salud Mental, Centurion, Cequr, Cereal Ingredients, Cerecor, Cerevance, Certara, Certis, Cerveau Technologies, CEVA, Ceva Sante Animale, Cevec Pharmaceuticals, CGA 369, CG Oncology, cGreen, Chameleon BioSurfaces, Changchun BCHT Biotechnology, Changshan Pharm, Chaperone Technologies, Charite Universitatsmedizin Berlin, Charles River Laboratories, Chart Industries, CheckedUp, Checkmate Pharmaceuticals, CheckPoint Immunology, Checkpoint Therapeutics, Chelexa Biosciences, Chembio Diagnostics, Chemesis, Chemi Pharmaceutical, ChemoCentryx, Chemstar, Chengdu Gaotong Isotope, Cheplapharm Arzneimittel, Chi-Med, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital of Philadelphia, Children's Medical Research Institute, Childrens Medical Center, Chimeric Therapeutics, Chimerix, China Grand Pharma, China Grand Pharmaceutical, China Medical System, China National Biotech Group (CNBG), China Oncology Focus, China Resources Sanjiu Medical and Pharmaceutical, Chinese University of Hong Kong, Chinook Therapeutics, Chiome Bioscience, Chondrial Therapeutics, Chong Kun Dang, Chongqing Jingdong Pharmaceutical, Chongqing Lummy Pharma, ChromaDex, Chromocell, Chronix Biomedical, Chugai Pharmaceutical, Chung-Ang University, Cibus Global, Cidara Therapeutics, Cilag AG, CimCure, Cincinnati Children’s Hospital Medical Center, CinCor Pharma, Cinda Bio-Pharmaceutical, Cingulate Therapeutics (CTx), Cipher Pharmaceuticals, Cipla, Circadian Wellness, Circassia, Circulogene, Cirle, Cisen Pharma, Citius Pharmaceuticals, Citranvi Biosciences, Citrine Medicine, Citron Pharma, City of Hope, Civetta Therapeutics, CiVi Biopharma, CJ Corp, Claremont BioSolutions, Claritas HealthTech, Clarity Pharmaceuticals, Clarus Therapeutics, ClearLight Biotechnologies, ClearLight Diagnostics, ClearPoint Neuro, Clearside Biomedical, Cleave Therapeutics, Cleveland Clinic, Cleveland Diabetes Care, Cleveland Diagnostics, Clevexel Pharma, Click Therapeutics, Clinical Laserthermia Systems (CLS), Clinigen, Clover Biopharmaceuticals, Clover Therapeutics, Clovis Oncology, CMC Biologics, CMS Medical, CN Bio, CNS Pharmaceuticals, Co-Diagnostics, Coalition for Epidemic Preparedness Innovations, Coapt, CoapTech, Coave Therapeutics, Cochlear, Cocoon Biotech, Cocrystal Pharma, Codex DNA, Codexis, Codiak BioSciences, Coeptis Pharmaceuticals, Cogentix Medical, Cognoa, CogState, Coherus Biosciences, CoImmune, Cold Spring Harbor, Collegium Pharmaceuticals, Collplant, Colorcon, Columbia Care, Columbia Laboratories, Columbia Technology Ventures, Columbia University, CombiGene, Combioxin, Comercializadora BioRenal, Commense, Common Sense, Compassionate Care Center of New York, Complix, Compugen, Conatus Pharmaceuticals, Concerto HealthAI, ConforMIS, Confo Therapeutics, Conkwest, Conmed, Consilient Health, ConsortiaTX, Consulting Group of Jocassee, ConSynance Therapeutics, Contamac, Context Therapeutics, Contextual Genomics, Convelo Therapeutics, ConverGene, Convergent Bioscience, Cook Biotech, Copernicus Therapeutics, Corbin Therapeutics, Corbus Pharmaceuticals, Corden Pharma, Cordis, Corestem, Corino Therapeutics, CorMedix, Cornell University, Coronado Biosciences, Correvio Pharma, Corsair Pharma, CorTechs Labs, Cortendo, Corteva Agriscience, Cortexyme, Corvidia Therapeutics, Corvium, Corvus Pharmaceuticals, Cosmo Pharmaceuticals, COUR Pharmaceutical, Covalon Technologies, Covance, COVAXX, Creative Biolabs, Creative Medical Technologies, Crescendo Biologics, Crescita Therapeutics, Cresset, CRISPR Therapeutics, Critical Diagnostics, Critical Path Services, CROMA Pharma, Crossbeta Biosciences, Crossject, Crown Bioscience, Crown Laboratories, CR Pharma, CRT Pioneer Fund, CrystalGenomics, CSIRO, CSL, CSL Behring, CSPC Pharmaceutical Group, CStone Pharmaceuticals, CTC Bio, CTT Pharmaceutical, CTX Technology, Cue Biopharma, Cullinan Oncology, Cumberland Pharmaceuticals, Cumulus Oncology, Curadev Pharma, Curative Biotechnology, CureMetrix, CURE Pharmaceutical, Cures Within Reach, Curetis, CureVac, Curis, Curium, Curon Biopharmaceutical, Currax Pharmaceuticals, Cutanea Life Sciences, Cutia Therapeutics, Cutting Edge Healthcare, CvergenX, Cyclacel Pharmaceuticals, Cyclenium Pharma, Cycle Pharmaceuticals, Cyclerion Therapeutics, Cyclica, Cyclopharm, CYduct Diagnostics, Cygnus, CymaBay Therapeutics, Cynata Therapeutics, Cyndea Pharma, Cyntar Ventures, Cyntec, Cyon Therapeutics, Cypralis, Cyprium Therapeutics, Cystic Fibrosis Foundation, Cystron Biotech, Cytocom, Cytodyn, CytoImmune Therapeutics, Cytokinetics, CytoLumina Technologies, CytomX Therapeutics, Cytos Biotechnology, CytoSen Therapeutics, Cytovance Biologics, Cytovant Sciences, CYTOVIA Therapeutics, CytRx, Cyxone, D. E. Shaw Research, D. Western Therapeutics Institute, D2M, Daewoong Pharmaceutical, Daiichi Sankyo, Dainippon Sumitomo Pharma, Daktari Diagnostics, Dalhousie University, Dana-Farber Cancer Institute, DARA BioSciences, Dare Bioscience, Dartmouth College, DarwinHealth, DAS Therapeutics, DATANet Software Development, Dauntless Pharmaceuticals, Dealmed Medical Supplies, Deargen, Debiopharm, Dechra Pharmaceuticals, Decibel Therapeutics, Deciphera Pharmaceuticals, de Duve Institute, Deep Genomics, Deerfield Management, DefiniGEN, DEG Productions, Deinove, Dekel Pharmaceuticals, Delcath Systems, Delivra, DelMar Pharmaceuticals, DelSiTech, Delta 9 Cannabis, DeMelle OncoPharma, Demetrix, Denali Therapeutics, DendroCyte, Denka, Denka-KEW Genomics, Denovo Biopharma, Densitas, Densmore Pharmaceutical, Department of Veterans Affairs, DepoMed, DePuy, Dermata Therapeutics, Dermavant Sciences, Dermelix Biotherapeutics, Dermira, Desitin, Desktop Genetics, Destiny Pharma, DeuteRx, Devonian Health Group, Dewpoint Therapeutics, DexCom, Diaccurate, diaDexus, DiA Imaging Analysis, Dialco Medical, DiaMedica, DIAN Diagnostics, Dianomi Therapeutics, Diaprost, Diatheva, DiCE Molecules, Dicerna Pharmaceuticals, Dignity Health, Dimension Therapeutics, DiNAQOR, DiosCURE Therapeutics, Disc Medicine, Distributed Bio, Diurnal, Diverse Biotech, Dixi, DKSH, DNA Script, DNAtrix, DNX Biopharmaceuticals, Dogma Therapeutics, DolCas Biotech, Domain Therapeutics, Dong-A Pharmaceutical, Dong-A ST, DongKoo Bio & Pharma, Door Pharmaceuticals, Dorian Therapeutics, DotBio, Dotmatics, Dow AgroSciences, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dr. U Devices, Draeger Safety Diagnostics, Dragonfly Therapeutics, DreaMed Diabetes, Dreamy, Drexel University, DRI Capital, Dr Kerklaan Therapeutics, Drug Innovation Ventures at Emory, DS Biopharma, DSM, DSM Sinochem Pharmaceuticals, Dual Therapeutics, DuChemBio, Duchesnay, Duke-NUS Graduate Medical School Singapore, Duke University, DuPont, Durect, Dutch SAZ, Dyadic International, DyDo Pharma, Dynacure, Dynamic Combinatorial Chemistry, Dyna Therapeutics, Dynavax Technologies, Dyno Therapeutics, E-Scape Bio, Eagle Pharmaceuticals, EA Pharma, Eastman Kodak, Easton Pharmaceuticals, Eberhard Karls University Tubingen, Echelon Fitness, ECM Therapeutics, Ecole Polytechnique Federale de Lausanne, Eczacibasi Pharmaceuticals, EDAP TMS, Eddingpharm, Edelris, Edesa Biotech, Edinburgh Innovations, Edison Oncology, Editas Medicine, Educational and Scientific, eFFECTOR Therapeutics, EffRx, Egalet, Ehave, EhmetDx, Eidos Therapeutics, Eiger BioPharmaceuticals, EirGenix, EirGen Pharma, Eirion Therapeutics, Eisai, Eisai Inc, Elanco, Elasmogen, Elcelyx Therapeutics, Elekta, Elektrofi, Elemaster Group, Elevar Therapeutics, Eleven Biotherapeutics, Elexopharm, Eligo Bioscience, Eli Lilly, Elis Pharmaceuticals, Elite Pharmaceuticals, Elixirgen, Ellipses Pharma, Elpis Biomed, Elpiscience, ElsaLys Biotech, Eltima Software, Eluminex Biosciences, Elysium Health, EmboMedics, Emcure Pharmaceuticals, Emendo Biotherapeutics, Emerald Organic Growth, Emerge Health, Emergence Therapeutics, Emergent BioSolutions, Emergex Vaccines, Emisphere, Emmaus Life Sciences, Emollivet, Emory University, Empatica, Empirico, Empowered Diagnostics, Enara Bio, Encore Dermatology, Endeavor BioMedicines, Endocanna Health, EndoCeutics, Endocyte, Endo International, EndoLogic, Endo Pharmaceuticals, Endo Ventures, Engage Therapeutics, enGene, EnGeneIC, Engitix, Engrail Therapeutics, Enigma Biomedical, Enleofen Bio, Enlibrium, Enochian Biosciences, ENPICOM, Ensemble Therapeutics, Ensoma, Entasis Therapeutics, Entera Health, Enteris Biopharma, Enterome Bioscience, Enterprise Therapeutics, Enthera, Entos Pharmaceuticals, Entrinsic Health Solutions, Enumeral Biomedical, Enveric Biosciences, EnWave, ENYO Pharma, Enzolytics, Enzymatica, Enzymotec, Enzyvant Science, EOC Pharma, Eolas Therapeutics, EOS Imaging, EpicentRx, Epic Pharmaceuticals, Epic Sciences, EpiDestiny, Epigen Biosciences, EPI Health, EpimAb Biotherapeutics, Epitomee Medical, Epivax, EpiVax Therapeutics, Epizyme, Epsilogen, Epygen Biotech, EQRx, Equillium, Equinox Science, Er-Kim, Ergomed, ERS Genomics, Ervaxx, ES Cell International, ESJ Enterprises, Especificos Stendhal, EspeRare Foundation, Esperion Therapeutics, Espero Biopharma, Establishment Labs, Esteve, ES Therapeutics, EtectRx, eTheRNA immunotherapies, Ethypharm, Eton Pharmaceuticals, Eucodis Bioscience, Eu Hwa, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eureka Therapeutics, Eurocine Vaccines, Eurofarma, Eurofins Genomics, Eurofins LifeCodexx, Eurofins Scientific, Euroimmun, European Commission, European Equity Partners, EUSA Pharma, Eutilex, Eve & Co, Evecxia, Evelo Biosciences, Event Cardio Group, Everads Therapy, Everest Medicines, EverInsight Therapeutics, Evestra, Evgen Pharma, Evolva, Evommune, Evonik Industries, EVOQ Therapeutics, Evotec, Evox Therapeutics, Evozyne, Ewopharma, Exact Sciences, Exagen Diagnostics, Excelimmune, ExcellaBio, ExCellThera, Excelra, Excision BioTherapeutics, Exelixis, Exeltis, Exicure, Exiqon, Exonics Therapeutics, ExoStat Medical, Exovita Biosciences, Expansion Therapeutics, Expedeon, ExpreS2ion Biotechnologies, Expression Therapeutics, ExScientia, Exzell Pharma, Eyam Vaccines and Immunotherapeutics, EyeCRO, Eyegate Pharmaceuticals, Eyenovia, Eyeon Therapeutics, EyePoint Pharmaceuticals, Eyevance, F-Star, F-Star Therapeutics, F1 Oncology, F2G, F4 Pharma, Facit, Factor Bioscience, Factorial Diagnostics, Faes Farma, Fagron, FairJourney Biologics, FameWave, Faraday Pharmaceuticals, Farmalider, FASMAC, Fate Therapeutics, Fatro, Fauna Bio, Fedora Pharmaceuticals, Feel Better, Feldan Therapeutics, Felix Biotechnology, Femtogenix, Ferozsons Laboratories, Ferring Pharmaceuticals, FetoLumina Technologies, FGH Biotech, Fibriant, Fibrocell Science, Fibrocor Therapeutics, Fibrogen, Fidia Farmaceutici, Fina Biosolutions, Finch Therapeutics, Fine Foods & Pharmaceuticals N.T.M., First Wave Bio, Fit for Life, FitOn, Five Prime Therapeutics, FKD Therapies, Flame Biosciences, Flamel Technologies, Flexion Therapeutics, FloDesign Sonics, Florida Pharmaceutical Products, Florida State University, Flow Eighteen38, Flower One, Flow Pharma, Fluicell, Fluidigm, Fluoresentric, Flynn Pharma, Flywheel, Foamix Pharmaceuticals, Foghorn Therapeutics, Fondazione San Raffaele, Fondazione Telethon, Food and Drug Administration (FDA), Forage Genetics, Forendo Pharma, Foresee Pharmaceuticals, Foresite Capital, Forge Therapeutics, Formac Pharmaceuticals, FORMA Therapeutics, Formula Pharmaceuticals, Forte Biotechnology, Fortify Therapeutics, Fortress Biotech, Forty Seven, Forward Pharma, Fosun Pharmaceutical, Foundation for Celiac Disease Outcome Measures, Foundation Medicine, Fox Chase Chemical Diversity Center, Fraunhofer Institute for Microelectronic Circuits and Systems, Fraunhofer Institute for Molecular Ecology (IME), Frazier Healthcare Ventures, Fred Hutchinson Cancer Research Center, Frequency Therapeutics, Fresenius Kabi Pharmaceuticals, Fresenius Medical Care, Frontier Biotech, Frontier Medicines, Front Range Biosciences, FSD Pharma, Fudan University, Fuhong Hanlin, Fujifilm, FUJIFILM Cellular Dynamics, Fujifilm Kyowa Kirin Biologics, Fuji Pharma, Fujirebio Diagnostics, Fuji Yakuhin, Fulcrum Therapeutics, Fulgent Genetics, Fulgent Pharma, Fundacion Medina, Fundacion Progreso y Salud, Fusion Antibodies, Fusion Pharmaceuticals, FuturaGene, FutureGen Biopharm, G+FLAS Life Sciences, G-Tech Bio, G-treeBNT, G1 Therapeutics, G3 Pharmaceuticals, Gadeta, Gaia, Galapagos, Galaxy Biotech, Galderma, Galen, Galena Biopharma, Galmed Pharmaceuticals, GamaMabs Pharma, Gan & Lee, GATC Health, GB Sciences, GC LabCell, GC Pharma, Gebro Pharma, Gedeon Richter, GE Healthcare, Gelesis, Gemini Therapeutics, GEMoaB, Gemphire, GEn1E Lifesciences, Gen9, Genagon Therapeutics, GenAhead Bio, Genco Sciences, GeneBay, Gene Biotherapeutics, GeneData, GenEdit, Genentech, Geneos Therapeutics, GeneQuine Biotherapeutics, Generex Biotechnology, Genesis Therapeutics, Genestack, Genethon, Genetic Analysis, Genetic Immunity, Genetic Information Research Institute, Genetics Research, Genetic Technologies, Genevant Sciences, Genexine, Genexo, Genfit, GenFleet Therapeutics, Genialis, Genisphere, Genkyotex, Genmab, Gennova Biopharmaceuticals, Genocea Biosciences, Genome Biologics, Genomic Health, Genomic Vision, Genomma Lab Internacional, Genor Biopharma, genOway, Genprex, GenScience Pharmaceuticals, GenScript Biotech, GenScript ProBio, GensKey Medical Technology, GenStem Therapeutics, GentiBio, Genticel, Genus, GenVec, Genzyme, George Mason University, Georgetown University, George Washington University, Georgia State University, Georgia State University Research Foundation (GSURF), Georgia Tech Research Corporation, German Cancer Research Center, Gestion Univalor, Ghent University, Gibson Oncology, Gilead Sciences, Ginkgo BioWorks, Glaukos, GlaxoSmithKline, GlaxoSmithKline Biologicals, GL Brands, Glenmark Pharmaceuticals, Global Antibiotic Research and Development Partnership, Global Blood Therapeutics, Global Cancer Diagnostics, Global Cancer Technology, Global Drug Development Centre (GDCC) China, Global Dx, Global Orthopaedic Technology, Global Response Aid, Globavir Biosciences, GlycoBac, Glycocept, GlycoMimetics, Glycostem Therapeutics, Glycotope Biotechnology, GlycoT Therapeutics, Glycyx Pharmaceuticals, Glythera, Gnosis Bioresearch, GNS Healthcare, Goethe University Frankfurt, Gold Coast Therapeutics, Goldfinch Bio, Goliver Therapeutics, Good Start Genetics, Goodwin Biotechnology, Google, Gossamer Bio, GO Therapeutics, Gour Medical, GPCR Therapeutics, Gracell Biotechnologies, Grail, Graviton Bioscience, Gravocore, GrayBug, Greatbatch, Great Belief International, Greenwich LifeSciences, Grenco Science, Grid Therapeutics, Grifols, Gritstone Oncology, Grunenthal, Grupo Ferrer, Grupo Juste, GS, GT Biopharma, GTx, Guangzhou Xiangxue Pharmaceutical, Gubra, Guided Therapeutics, Guohong Guokang (Beijing) Health Technology Development, Gurnet Point Capital, Gynial, Gyroscope Therapeutics, Gyros Protein Technologies, H&P Labs, H3 Biomedicine, Hackensack Meridian Health, Hadasit Bioholdings, Hadasit Medical Research Services and Development, Hai Kang Life, Hainan Sinotau Pharmaceutical, Hairmore Group, Haisco Pharmaceutical, HalioDx, Halo Dx, Halo Labs, Halozyme Therapeutics, Halt Medical, Halyard Health, Hamad Medical, Hamamatsu Photonics, Hammock Pharmaceuticals, HanAll Pharmaceuticals, HanaVax


For a full list of companies please contact us on

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!